Evidence map›Paper›PMID 38704250›Full record

ArticleVaccine2024

Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February-1 March 2024.

Philipp Lambach, Sheetal Silal, Alyssa N Sbarra, Mitsuki Koh, Rakesh Aggarwal, Habib Hasan Farooqui, Stefan Flasche, Alexandra B Hogan, Sun-Young Kim, Kathy Leung and 5 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. How users perceive meta-analysis of economic evaluations.International journal of technology assessment in health care · 2026
    Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Philipp LambachImmunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Sheetal SilalModelling and Simulation Hub, Africa, University of Cape Town, Cape Town, South Africa; Centre for Global Health, Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
Alyssa N SbarraJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. Electronic address: asbarra1@jhu.edu.
Mitsuki KohImmunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Rakesh AggarwalJawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India.
Habib Hasan FarooquiCollege of Medicine, QU Health, Qatar University, Qatar.
Stefan FlascheCentre for Global Health, Charite, Berlin, Germany.
Alexandra B HoganSchool of Population Health, University of New South Wales, Sydney, Australia.
Sun-Young KimSeoul National University, Seoul, South Korea.
Kathy LeungSchool of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region.
William J MossJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Patrick K MunywokiKenya Medical Research Institute, Centre for Global Health Research, Nairobi, Kenya.
Allison PortnoyDepartment of Global Health, Boston University School of Public Health, Boston, United States; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, United States.
Meru SheelSchool of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Xuan-Yi WangShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.

Funding

World Health Organization 001
6 · The paper itself

Abstract

The Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC) is the World Health Organization's key standing advisory body to conduct an independent review of research, particularly of transmission and economic modeling analyses that estimate the impact and value of vaccines. From 26th February-1st March 2024, at its first of two semi-annual meetings, IVIR-AC provided feedback and recommendations across four sessions; this report summarizes the proceedings and recommendations from that meeting. Session topics included modeling of the impact and cost-effectiveness of the R21/Matrix-M malaria vaccine, meta-analysis of economic evaluations of vaccines, a global analysis estimating the impact of vaccination over the last 50 years, and modeling the impact of different RTS,S malaria vaccine dose schedules in seasonal settings.

Indexed as

Advisory CommitteesMalaria VaccinesWorld Health OrganizationCost-Benefit AnalysisHumansImmunizationMalariaVaccinationMalaria VaccinesEconomic evaluationEPIIVIR-ACMalariaMeta-analysis

Identifiers

PMID38704250
PMCPMC11128797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.